Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry
Background Transcatheter aortic valve replacement with supra‐annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves. The next generation self‐expanding Evolut PRO valve has not been evaluated in patients with surgical valve failure. Methods and Result...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/760bfd2b86c047fda4ec7e34de9fdea2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:760bfd2b86c047fda4ec7e34de9fdea2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:760bfd2b86c047fda4ec7e34de9fdea22021-11-23T11:36:34ZTranscatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry10.1161/JAHA.121.0218712047-9980https://doaj.org/article/760bfd2b86c047fda4ec7e34de9fdea22021-09-01T00:00:00Zhttps://www.ahajournals.org/doi/10.1161/JAHA.121.021871https://doaj.org/toc/2047-9980Background Transcatheter aortic valve replacement with supra‐annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves. The next generation self‐expanding Evolut PRO valve has not been evaluated in patients with surgical valve failure. Methods and Results Patients undergoing transcatheter aortic valve replacement in degenerated surgical aortic valve procedures using the Evolut R or Evolut PRO transcatheter heart valves in the Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry between April 2015 and June 2019 were evaluated. Transcatheter valve performance was evaluated by clinical site echocardiography. In‐hospital, 30‐day, and 1‐year clinical outcomes were based on the Society of Thoracic Surgeons‐American College of Cardiology‐Transcatheter Valve Therapy registry definitions. Transcatheter aortic valve replacement in degenerated surgical aortic valve was performed in 5897 patients (5061 [85.8%] patients received the Evolut R valve and 836 [14.2%] received the Evolut PRO valve). Thirty‐day transcatheter heart valves hemodynamic performance was excellent in both groups (mean gradient: Evolut PRO: 13.8±7.5 mm Hg; Evolut R: 14.5±8.1 mm Hg), while paravalvular regurgitation was significantly different between valve types (P=0.02). Clinical events were low at 30 days (Evolut PRO: for the all‐cause mortality, 2.8%, any stroke was 1.8%, new pacemaker implantation, 3.0%: Evolut R:all‐cause mortality, 2.5%, any stroke was 2.2%, new pacemaker implantation, 5.3%) and 1 year (Evolut PRO: all‐cause mortality, 9.2%; any stroke, 3.1%; Evolut R: all‐cause mortality, 9.8%; any stroke, 2.9%). Conclusions Transcatheter aortic valve replacement in degenerated surgical aortic valve with self‐expandable supra‐annular transcatheter heart valves is associated with excellent clinical outcomes and valve hemodynamics. Additional reductions in residual paravalvular regurgitation were obtained with the next generation Evolut PRO.Luis Augusto P. DallanJohn K. ForrestMichael J. ReardonWilson Y. SzetoIsaac GeorgeSusheel KodaliNeal S. KleimanSteven J. YakubovKendra J. GrubbFang LiuCristian BaezaGuilherme F. AttizzaniWileyarticlesurgical aortic valve replacementtranscatheter aortic valve replacement in degenerated surgical aortic valvetranscatheter aortic valve replacementvalve‐in‐valveDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 18 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
surgical aortic valve replacement transcatheter aortic valve replacement in degenerated surgical aortic valve transcatheter aortic valve replacement valve‐in‐valve Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
surgical aortic valve replacement transcatheter aortic valve replacement in degenerated surgical aortic valve transcatheter aortic valve replacement valve‐in‐valve Diseases of the circulatory (Cardiovascular) system RC666-701 Luis Augusto P. Dallan John K. Forrest Michael J. Reardon Wilson Y. Szeto Isaac George Susheel Kodali Neal S. Kleiman Steven J. Yakubov Kendra J. Grubb Fang Liu Cristian Baeza Guilherme F. Attizzani Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry |
description |
Background Transcatheter aortic valve replacement with supra‐annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves. The next generation self‐expanding Evolut PRO valve has not been evaluated in patients with surgical valve failure. Methods and Results Patients undergoing transcatheter aortic valve replacement in degenerated surgical aortic valve procedures using the Evolut R or Evolut PRO transcatheter heart valves in the Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry between April 2015 and June 2019 were evaluated. Transcatheter valve performance was evaluated by clinical site echocardiography. In‐hospital, 30‐day, and 1‐year clinical outcomes were based on the Society of Thoracic Surgeons‐American College of Cardiology‐Transcatheter Valve Therapy registry definitions. Transcatheter aortic valve replacement in degenerated surgical aortic valve was performed in 5897 patients (5061 [85.8%] patients received the Evolut R valve and 836 [14.2%] received the Evolut PRO valve). Thirty‐day transcatheter heart valves hemodynamic performance was excellent in both groups (mean gradient: Evolut PRO: 13.8±7.5 mm Hg; Evolut R: 14.5±8.1 mm Hg), while paravalvular regurgitation was significantly different between valve types (P=0.02). Clinical events were low at 30 days (Evolut PRO: for the all‐cause mortality, 2.8%, any stroke was 1.8%, new pacemaker implantation, 3.0%: Evolut R:all‐cause mortality, 2.5%, any stroke was 2.2%, new pacemaker implantation, 5.3%) and 1 year (Evolut PRO: all‐cause mortality, 9.2%; any stroke, 3.1%; Evolut R: all‐cause mortality, 9.8%; any stroke, 2.9%). Conclusions Transcatheter aortic valve replacement in degenerated surgical aortic valve with self‐expandable supra‐annular transcatheter heart valves is associated with excellent clinical outcomes and valve hemodynamics. Additional reductions in residual paravalvular regurgitation were obtained with the next generation Evolut PRO. |
format |
article |
author |
Luis Augusto P. Dallan John K. Forrest Michael J. Reardon Wilson Y. Szeto Isaac George Susheel Kodali Neal S. Kleiman Steven J. Yakubov Kendra J. Grubb Fang Liu Cristian Baeza Guilherme F. Attizzani |
author_facet |
Luis Augusto P. Dallan John K. Forrest Michael J. Reardon Wilson Y. Szeto Isaac George Susheel Kodali Neal S. Kleiman Steven J. Yakubov Kendra J. Grubb Fang Liu Cristian Baeza Guilherme F. Attizzani |
author_sort |
Luis Augusto P. Dallan |
title |
Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry |
title_short |
Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry |
title_full |
Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry |
title_fullStr |
Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry |
title_full_unstemmed |
Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry |
title_sort |
transcatheter aortic valve replacement with self‐expandable supra‐annular valves for degenerated surgical bioprostheses: insights from transcatheter valve therapy registry |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/760bfd2b86c047fda4ec7e34de9fdea2 |
work_keys_str_mv |
AT luisaugustopdallan transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT johnkforrest transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT michaeljreardon transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT wilsonyszeto transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT isaacgeorge transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT susheelkodali transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT nealskleiman transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT stevenjyakubov transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT kendrajgrubb transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT fangliu transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT cristianbaeza transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry AT guilhermefattizzani transcatheteraorticvalvereplacementwithselfexpandablesupraannularvalvesfordegeneratedsurgicalbioprosthesesinsightsfromtranscathetervalvetherapyregistry |
_version_ |
1718416772336451584 |